Opinions
Matthew McCall
GW Pharmaceuticals PLC
GWPH-Q
PAST TOP PICK
Jun 05, 2017
$99.650
Stock price when the opinion was issued
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
TOP PICK
A UK company. They use synthetic cannabinoids to create drugs that are used to fight seizures and pain. This has been lumped into the cannabis/marijuana sector. Had their phase 3 updated results for a drug for seizures in children under 1 year of age. In the next month, there are 2 phase 3 trials that are coming in from the FDA, and he believes that 1, possibly 2 are going to be approved.
Pharma & Healthcare
Advertising
(Top Pick Jun 1/16, Up 7%) He bought and sold it a few different times in the last year. They make several drugs. They have several trials with positive news having come out in the last year. One or two new drugs will get approved in the next year. He still likes it, but keep in mind the aggressiveness that comes with it.